The essential context.
- More hunger does not establish better recovery or muscle gain.
- Diagnostic use evaluates endocrine function rather than athletic enhancement.
- The hormonal effects are not necessarily confined to GH.
Why GHRP-2 interests physique athletes
In bodybuilding discussions, GHRP-2 is associated with increased appetite, muscle gain and recovery through growth-hormone signalling. Appetite is sometimes described as a benefit for someone struggling to eat enough. Yet the direction of a biological effect is not the same as a health advantage.
More food intake could conflict with a different goal, and bodyweight gain is not proof of muscle growth. The relevant questions are whether training function improves, what tissue changes and whether unwanted effects outweigh the supposed gain. Those questions require more than a strong hormone response.
From hunger to a claimed training result
Different levels of evidence answer different questions.
Signal
Ghrelin-related receptor activity
Measured
Hunger, food intake and hormones
Unmeasured
Training adaptation and function
Balance
Side effects and product identity remain relevant
The appetite studies: specific and limited
Laferrère and colleagues' 2005 study in seven lean men reported greater food intake after GHRP-2 than placebo. Their 2006 Obesity study extended the appetite investigation to 19 lean or obese adults. Both were short experimental studies, not muscle-building trials.
These papers are useful because they measured an actual behavioural endpoint. They do not show that extra intake becomes contractile muscle or improves recovery. Extrapolating from a controlled meal to months of training introduces questions the studies were not designed to answer.
What the diagnostic research adds
Chihara and colleagues' 2007 European Journal of Endocrinology study compared 77 healthy participants with 58 patients in evaluating a GHRP-2 test for adult GH deficiency. Its purpose was diagnosis. A stimulated hormone response helped distinguish endocrine groups.
That clinical use must not be recast as evidence for a training aid. Testing pituitary function in an assessed patient is different from trying to increase hormone output in a healthy athlete. The same measured molecule can be a useful diagnostic signal without being a demonstrated sporting benefit.
Potential advantages versus the outcomes actually measured
A plausible research role exists in understanding appetite and hormone regulation. A proven sports advantage would require direct measures such as strength, injury function or maintained exercise capacity. The cited work does not provide those results.
An appetite response is also not equivalent to correcting an energy problem. Poor appetite, unintended weight loss or persistent low energy can have different causes. A sports-health assessment should investigate the complaint rather than assume that pharmacologically increasing hunger solves the underlying problem.
| Claim | Evidence | Limit |
|---|---|---|
| More appetite | Short human food-intake experiments | Not a muscle-gain outcome |
| Higher GH response | Endocrine and diagnostic studies | Not a quantified performance gain |
| Better recovery | A promotional expectation | Direct athlete evidence missing |
Risks beyond the preferred hormone
Arvat and colleagues' 1997 Peptides experiment found GHRP-2 and hexarelin influenced additional endocrine measurements, including prolactin and the ACTH–cortisol axis. The response was not exclusively a GH effect. A mechanistic description that omits this detail is incomplete.
These small experiments cannot determine the long-term clinical consequences or rank every secretagogue's safety. Acute hormone values and a chronic disorder are not interchangeable. The responsible interpretation is that endocrine effects extend beyond the desired signal and need appropriate clinical evidence.
Why personal experience cannot settle the balance
Training changes, calorie intake, other substances and expectations can all complicate a before-and-after account. A user noticing more hunger has not thereby demonstrated improved recovery. A higher scale weight also cannot tell us how much functional muscle, fat or fluid changed.
Product quality is another independent uncertainty. An authenticated study substance cannot certify a separate catalogue vial. Without reliable identity and batch documentation, the literature cannot establish what material produced a reported effect or what additional hazards it carried.
Competition and what remains unknown
WADA 2026: GHRP-2 is prohibited at all times under S2.
The studies support specific physiological observations. They do not supply a dependable benefit–risk estimate for healthy athletes pursuing hypertrophy or recovery. Future sport-relevant research would need verified material, appropriate comparison groups, direct functional endpoints and enough follow-up to assess harms.
Frequently asked questions
Is increased appetite a proven muscle-building benefit?
No. Food intake was measured, but conversion into useful muscle and better performance was not established.
Does diagnostic use make sporting use equivalent?
No. A test for endocrine disease and enhancement in a healthy person involve different objectives and evidence.
Does GHRP-2 affect only growth hormone?
No. Human endocrine work also recorded responses outside the GH axis.
Sources & further reading
Key publications are named below. The article explains their design, study population and limitations, keeping laboratory findings, clinical results and sports claims in context.
- 01 Laferrère et al. (2005), J Clin Endocrinol Metab: GHRP-2 and food intake. PMID 15699539.
- 02 Laferrère et al. (2006), Obesity: GHRP-2 appetite responses in lean and obese adults. PMID 16861611.
- 03 Chihara et al. (2007), Eur J Endocrinol: GHRP-2 diagnostic testing. PMID 17609397.
- 04 Arvat et al. (1997), Peptides: endocrine responses to GHRP-2 and hexarelin. PMID 9285939.
- 05 WADA: 2026 List.
Dr. Monica Tatem
Dr. Monica Tatem earned her Ph.D. in Molecular Pharmacology from a leading medical university, followed by postdoctoral research focused on anabolic pathways and cellular signaling. Her scientific work encompasses a comprehensive...
View author profile